BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ryan A. Azoreductases in drug metabolism. Br J Pharmacol. 2017;174:2161-2173. [PMID: 27487252 DOI: 10.1111/bph.13571] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Xue T, Shao K, Xiang J, Pan X, Zhu Z, He Y. In situ construction of a self-assembled AIE probe for tumor hypoxia imaging. Nanoscale 2020;12:7509-13. [PMID: 32227022 DOI: 10.1039/d0nr00444h] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
2 Misal SA, Gawai KR. Azoreductase: a key player of xenobiotic metabolism. Bioresour Bioprocess 2018;5. [DOI: 10.1186/s40643-018-0206-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 8.3] [Reference Citation Analysis]
3 Flowers SA, Bhat S, Lee JC. Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy 2020;40:704-12. [DOI: 10.1002/phar.2428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ngo ACR, Tischler D. Microbial Degradation of Azo Dyes: Approaches and Prospects for a Hazard-Free Conversion by Microorganisms. IJERPH 2022;19:4740. [DOI: 10.3390/ijerph19084740] [Reference Citation Analysis]
5 Choi J, Park MH, Shin SH, Byeon JJ, Lee BI, Park Y, Shin YG. Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry. Molecules 2021;26:1179. [PMID: 33671835 DOI: 10.3390/molecules26041179] [Reference Citation Analysis]
6 Dunkel P, Ilaš J. Targeted Cancer Therapy Using Compounds Activated by Light. Cancers (Basel) 2021;13:3237. [PMID: 34209493 DOI: 10.3390/cancers13133237] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Bafana A, Khan F, Suguna K. Purification, characterization, and crystal structure of YhdA-type azoreductase from Bacillus velezensis. Proteins 2021;89:483-92. [PMID: 33289153 DOI: 10.1002/prot.26032] [Reference Citation Analysis]
8 Ryan A. Azoreductases in drug metabolism. Br J Pharmacol. 2017;174:2161-2173. [PMID: 27487252 DOI: 10.1111/bph.13571] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
9 Suzuki H. Remarkable diversification of bacterial azoreductases: primary sequences, structures, substrates, physiological roles, and biotechnological applications. Appl Microbiol Biotechnol 2019;103:3965-78. [PMID: 30941462 DOI: 10.1007/s00253-019-09775-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
10 Mulatihan D, Guo T, Zhao Y. Azobenzene Photoswitch for Isomerization-Dependent Cancer Therapy via Azo-Combretastatin A4 and Phototrexate. Photochem Photobiol 2020;96:1163-8. [PMID: 32521572 DOI: 10.1111/php.13292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
11 Cerón-Carrasco JP, Jacquemin D. Using Theory To Extend the Scope of Azobenzene Drugs in Chemotherapy: Novel Combinations for a Specific Delivery. ChemMedChem 2021;16:1764-74. [PMID: 33619857 DOI: 10.1002/cmdc.202100046] [Reference Citation Analysis]
12 Chevalier A, Renard P, Romieu A. Azo-Based Fluorogenic Probes for Biosensing and Bioimaging: Recent Advances and Upcoming Challenges. Chem Asian J 2017;12:2008-28. [DOI: 10.1002/asia.201700682] [Cited by in Crossref: 57] [Cited by in F6Publishing: 33] [Article Influence: 11.4] [Reference Citation Analysis]
13 Yan VC, Butterfield HE, Poral AH, Yan MJ, Yang KL, Pham CD, Muller FL. Why Great Mitotic Inhibitors Make Poor Cancer Drugs. Trends Cancer 2020;6:924-41. [PMID: 32536592 DOI: 10.1016/j.trecan.2020.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
14 Copp JN, Pletzer D, Brown AS, Van der Heijden J, Miton CM, Edgar RJ, Rich MH, Little RF, Williams EM, Hancock REW, Tokuriki N, Ackerley DF. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections. mBio 2020;11:e02068-20. [PMID: 32934086 DOI: 10.1128/mBio.02068-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
15 Verma K, Saha G, Kundu LM, Dubey VK. Biochemical characterization of a stable azoreductase enzyme from Chromobacterium violaceum: Application in industrial effluent dye degradation. International Journal of Biological Macromolecules 2019;121:1011-8. [DOI: 10.1016/j.ijbiomac.2018.10.133] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
16 Scher JU, Nayak RR, Ubeda C, Turnbaugh PJ, Abramson SB. Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. Nat Rev Rheumatol 2020;16:282-92. [PMID: 32157196 DOI: 10.1038/s41584-020-0395-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
17 Kannigadu C, Aucamp J, N'Da DD. Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide. Drug Dev Res 2021;82:287-95. [PMID: 33141473 DOI: 10.1002/ddr.21755] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Thomas C, Gwenin CD. The Role of Nitroreductases in Resistance to Nitroimidazoles. Biology (Basel) 2021;10:388. [PMID: 34062712 DOI: 10.3390/biology10050388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Sohail G, Xu X, Christman MC, Tompkins TA. Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis. World J Clin Cases 2018; 6(15): 961-984 [PMID: 30568952 DOI: 10.12998/wjcc.v6.i15.961] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Walsh J, Griffin BT, Clarke G, Hyland NP. Drug-gut microbiota interactions: implications for neuropharmacology. Br J Pharmacol 2018;175:4415-29. [PMID: 29782640 DOI: 10.1111/bph.14366] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
21 Tian Y, Li Y, Jiang W, Zhou D, Fei J, Li C. In-Situ Imaging of Azoreductase Activity in the Acute and Chronic Ulcerative Colitis Mice by a Near-Infrared Fluorescent Probe. Anal Chem 2019;91:10901-7. [DOI: 10.1021/acs.analchem.9b02857] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
22 Xue T, Jia X, Wang J, Xiang J, Wang W, Du J, He Y. “Turn‐On” Activatable AIE Dots for Tumor Hypoxia Imaging. Chem Eur J 2019;25:9634-8. [DOI: 10.1002/chem.201902296] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
23 Basharat Z, Yasmin A. Sulphonated azo dye decolorization by Alcaligenes faecalis subsp. phenolicus MB207: Insights from laboratory and computational analysis. Biophysical Chemistry 2022. [DOI: 10.1016/j.bpc.2022.106806] [Reference Citation Analysis]
24 Sidhu JS, Kaur N, Singh N. Trends in small organic fluorescent scaffolds for detection of oxidoreductase. Biosens Bioelectron 2021;191:113441. [PMID: 34167075 DOI: 10.1016/j.bios.2021.113441] [Reference Citation Analysis]
25 Zhu C, Zou Z, Huang C, Zheng J, Liu N, Li J, Yang R. Highly selective imaging of lysosomal azoreductase under hypoxia using pH-regulated and target-activated fluorescent nanoprobes. Chem Commun 2019;55:3235-8. [DOI: 10.1039/c9cc00462a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
26 Liu H, Yang J, Yan X, Li C, Elsabahy M, Chen L, Yang YW, Gao H. A dendritic polyamidoamine supramolecular system composed of pillar[5]arene and azobenzene for targeting drug-resistant colon cancer. J Mater Chem B 2021;9:9594-605. [PMID: 34783814 DOI: 10.1039/d1tb02134f] [Reference Citation Analysis]
27 Zuma NH, Aucamp J, N'da DD. An update on derivatisation and repurposing of clinical nitrofuran drugs. European Journal of Pharmaceutical Sciences 2019;140:105092. [DOI: 10.1016/j.ejps.2019.105092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]